HEALIOS K.K.
Research HEALIOS K.K. (6VX) on Bullrun: market cap EUR 179.55M, P/E 133.0. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker6VX
- ExchangeF
- CountryJapan
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 179.55M
- P/E133.0
- Financial periodFY2025
- RevenueJPY 104.00M
- Revenue growth-81.4%
- Net income-JPY 2.22B
- Free cash flow-JPY 3.33B
- Gross margin-109.6%
Valuation Snapshot
latest market cap is EUR 179.55M; P/E is 133.0.
Peer valuation comparison
Latest P/E is 133x versus a Healthcare sector median of 24.46x (443.7% above).
Latest P/E is 133x versus a Japan median of 16.54x (704.1% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | JPY 104.00M | -JPY 2.22B | -JPY 3.33B | -109.6% | n/a | JPY 5.68B | JPY 2.61B | JPY 4.89B |
| FY2024 | JPY 560.00M | -JPY 4.24B | -JPY 2.12B | 77.1% | -47.86 | JPY 3.67B | JPY 2.66B | JPY 2.06B |
| FY2023 | JPY 121.00M | -JPY 3.82B | -JPY 2.85B | 90.1% | -56.22 | JPY 6.72B | JPY 4.53B | JPY 3.86B |
| FY2022 | JPY 90.00M | -JPY 5.17B | -JPY 4.86B | 100.0% | -90.67 | JPY 7.25B | JPY 7.15B | JPY 4.38B |
| FY2021 | n/a | n/a | n/a | n/a | -99.51 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | EUR 179.55M | 133.0 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About HEALIOS K.K.
Healios K.K., together with its subsidiaries, engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051, which is preparing for approval for the treatment of acute respiratory distress syndrome; HLCM051, which is preparing for phase 3 clinical trial for the treatment of ischemic stroke;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is HEALIOS K.K.'s market cap?
HEALIOS K.K.'s market capitalization is EUR 179.55M.
What is HEALIOS K.K.'s P/E ratio?
HEALIOS K.K.'s price-to-earnings (P/E) ratio is 133.0.
What does HEALIOS K.K. do?
Healios K.K., together with its subsidiaries, engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.